Prioritizing treatment attributes and their impact on selecting an oral triptan: results from the TRIPSTAR Project.

被引：11
作者：
Dodick D.W. [1 ]
Lipton R.B. [1 ]
Ferrari M.D. [1 ]
Goadsby P.J. [1 ]
McCrory D. [1 ]
Cutrer F.M. [1 ]
Williams P. [1 ]
机构：
[1] Department of Neurology, Mayo Clinic Scottsdale, 85259, AZ
来源：
Current Pain and Headache Reports | 2004年 / 8卷 / 6期
关键词：
Migraine; Analytic Hierarchy Process; Sumatriptan; Zolmitriptan; Rizatriptan;
D O I：
10.1007/s11916-004-0064-2
中图分类号：
学科分类号：
摘要：
Seven oral triptans, which differ on a range of attributes important for treatment selection, are now available for treating migraine. US neurologists were surveyed to assess the relative importance of treatment attributes, prespecified by clinical relevance and availability of controlled study data, for selecting among oral triptans. Using a multiattribute decision model, we combined these data on the importance of treatment attributes with information on the relative performance of the oral triptans derived from a recent meta-analysis of controlled clinical trials.
引用
收藏
页码：435 / 442
页数：7
相关论文
共 66 条
[1]  
Lipton RB(2001)Prevalence and burden of migraine in the United States: data from the American Migraine Study II Headache 41 646-657
[2]  
Stewart WF(2000)The global burden of disease study: implications for neurology Arch Neurol Mar 57 418-420
[3]  
Diamond S(2002)Migraine: current understanding and treatment N Engl J Med 346 257-270
[4]  
Menken M(1999)Acute migraine therapy: Do doctors understand what patients with migraine want from therapy? Headache 39 S20-S26
[5]  
Munsat TL(2000)Determinants of patient satisfaction with migraine therapy Cephalalgia 20 554-560
[6]  
Toole JF(2003)Migraine medication attributes important for patient compliance: concerns about side effects may delay treatment Headache 43 36-44
[7]  
Goadsby PJ(1998)Medical consultation for migraine: results form the American Migraine Study Headache 38 87-96
[8]  
Lipton RB(2001)Oral triptans (serotonin 5-HT1B/1D agonists) in acute migraine treatment: a meta-analysis of 53 trials Lancet 358 1668-1675
[9]  
Ferrari MD(2002)Triptans (serotonin, 5-HT1B/1D agonists) in migraine: detailed results and methods of a meta-analysis of 53 trials Cephalalgia 22 633-658
[10]  
Lipton RB(2000)Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology Neurology 55 754-762
1234567